Pharma channel feed

Evotec’s CNS deal with Bris­tol My­ers gets $50M in­fu­sion and eight-year ex­ten­sion

3 years ago
Deals

Gun­ning for 2023 ap­proval, GSK de­tails PhI­II da­ta for Jem­per­li in front­line en­dome­tri­al can­cer

3 years ago
R&D

Es­pe­ri­on sues Dai­ichi Sankyo, de­mand­ing pay­ment of $300M mile­stone for car­dio drug

3 years ago
Law

Mer­ck KGaA takes back con­trol of PD-L1 can­cer drug as Pfiz­er al­liance ends

3 years ago
Deals

Eli Lil­ly to in­crease in­vest­ment to $1B in­to new Irish man­u­fac­tur­ing fa­cil­i­ty — re­port

3 years ago
Manufacturing

Sen­a­tor asks FTC to in­ves­ti­gate Amerisource­Ber­gen over abor­tion pill dis­tri­b­u­tion plans

3 years ago

Re­silience notch­es $410M in fed­er­al fi­nanc­ing to bol­ster pro­duc­tion

3 years ago
Financing
Manufacturing

BioN­Tech read­ies for plunge in Covid sales, will boost mR­NA and on­col­o­gy pipelines

3 years ago

Eu­ro­pean doc­tors di­al up dig­i­tal com­mu­ni­ca­tion with phar­mas, but still lean to­ward in-per­son med meet­ings, study finds

3 years ago
Marketing

Judge al­lows ex­pert tes­ti­mo­ny in GSK tri­al al­leg­ing Zan­tac link to can­cer

3 years ago
Law

No­vo Nordisk oral semaglu­tide tri­al shows re­duc­tion in blood sug­ar, plus weight loss

3 years ago
R&D

Ab­bott in­tro­duces the Mel­on fam­i­ly to raise con­cus­sion aware­ness

3 years ago
Marketing

Sen­ate com­mit­tee ad­vances PBM bill as bi­par­ti­san re­forms gain trac­tion

3 years ago
Law

Ly­me vac­cine test com­ple­tion is pushed back by a year as Pfiz­er, Val­ne­va say they'll ad­just tri­al

3 years ago
R&D

In­cyte hit by CRL on ex­tend­ed-re­lease JAK tablets, mud­dy­ing plans for Jakafi fran­chise ex­pan­sion

3 years ago
FDA+

Take­da and Lund­beck change tac­tics on Trin­tel­lix de­pres­sion cam­paign

3 years ago
Marketing

Eu­ro­pean Com­mis­sion de­lays pro­pos­al for ma­jor changes to phar­ma leg­is­la­tion

3 years ago
FDA+

Bris­tol My­ers’ ‘Liv­ing’ doc­u­men­tary ties to­geth­er peo­ple man­ag­ing health con­di­tions

3 years ago
Marketing

Se­cu­ra Bio to keep of­fer­ing blood can­cer drug de­spite neg­a­tive ODAC vote, OS ques­tions

3 years ago

J&J los­es at­tempt to ex­tend patent in In­dia for tu­ber­cu­lo­sis drug

3 years ago

White House un­veils ‘bold goals’ for US bio­man­u­fac­tur­ing ef­forts

3 years ago
Manufacturing

Take­da in­vests $760M+ in­to new plas­ma-de­rived ther­a­py man­u­fac­tur­ing site in Japan

3 years ago
Manufacturing

Sanofi, Re­gen­eron boast PhI­II win with Dupix­ent in COPD, clear­ing first bar for ex­pan­sion

3 years ago
R&D

FDA ad­vi­sors unan­i­mous­ly rec­om­mend ac­cel­er­at­ed ap­proval for Bio­gen's ALS drug

3 years ago
FDA+
First page Previous page 136137138139140141142 Next page Last page
A service from the Financial Times